ESMO Recognizes Young Researchers at ESMO AI 2026
ESMO/ LinkedIn

ESMO Recognizes Young Researchers at ESMO AI 2026

ESMO – European Society for Medical Oncology shared on LinkedIn:

“Congratulations to the ESMO Merit Award recipients at ESMOAI26.

As part of ESMO’s commitment to supporting the next generation within the Oncology Community, we recognise these young researchers for the scientific merit of their abstracts.”

ESMOAI26 is a major international medical conference focused on how artificial intelligence and digital technology are used to fight cancer. 
 
Officially called the ESMO AI & Digital Oncology Congress 2026, it is hosted by the European Society for Medical Oncology (ESMO) and is currently taking place in Berlin, Germany, and online from November 16 to 18, 2026.

The main goal of the event is to bring together cancer doctors, researchers, data scientists, and tech developers to figure out how to safely use AI in real-world cancer care.

Specifically, it is used for:

  • Improving patient care: Discussing how AI tools can help doctors spot cancer earlier, predict how a patient will respond to treatment, and personalize therapies.
  • Advancing research: Sharing new ways to use computer models and large amounts of patient data to speed up clinical trials and discover new drugs.
  • Setting safety rules: Debating the ethics, privacy concerns, and legal guidelines needed to make sure AI is reliable and safe before it is used in hospitals.

You can also read:

How Can AI Transform Cancer Research and Patient Care Responsibly? – ESMO

ESMO Recognizes Young Researchers at ESMO AI 2026